Ethylene-vinyl Acetate (EVA) Infusion Bags Market: Introduction
According to the report, the global ethylene-vinyl acetate (EVA) infusion bags market was valued at ~US$ 128 Mn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030. Rise in awareness about parenteral nutrition therapy and high prevalence and increase in incidence of chronic kidney diseases are anticipated to drive the global ethylene-vinyl acetate (EVA) infusion bags market from 2020 to 2030. North America is expected to account for a significant share of the global ethylene-vinyl acetate (EVA) infusion bags market during the forecast period. The growth of the market in the region can be attributed to increase in demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides for the treatment of cancer, neurological diseases, and chronic kidney diseases. Rise in prevalence of lifestyle diseases, surge in healthcare spending, and strong economy are likely to contribute to North America’s dominance of the global ethylene-vinyl acetate (EVA) infusion bags market during the forecast period.
The market in Asia Pacific is projected to expand at a high CAGR of 7.3% from 2020 to 2030. This can be attributed to the expansion of the healthcare sector in countries such as China, Japan, and India. Moreover, development and increase in sales of biological drugs in countries such as Japan, India, and China are anticipated to propel the market in the region during the forecast period.
Rise in Awareness about Parenteral Nutrition Therapy to Propel Market
Parenteral nutrition (PN) is intravenous administration of nutrients for nourishment, which could incorporate protein, starch, fat, minerals, electrolytes, vitamins, and other trace components for patients who cannot eat or ingest in adequate quantity with the help of a tube. Accomplishing the privilege nutritious admission in the prescribed way can help battle complexities and is a crucial part of the patient's recuperation. Parenteral nutrition is also called total parenteral nutrition (TPN). EVA has a successful and long history in parenteral applications. Currently, EVA bags are used for intravenous delivery of total parenteral nutrition (TPN). Additionally, EVA bags are used in parenteral delivery of compounding fluids. Often, various medications are mixed together using ingredients or drugs. For instance, fluid resulting from compounding parenteral nutrition and chemotherapy drugs.
The primary purpose of parenteral nourishment is to provide sufficient dietary help to the continually sick patients. High rate of diseases such as malignancy, gastro-intestinal disorders, ischemic gut malady, diabetic intricacies, and Crohn's disease is shifting interest toward parenteral nourishment. According to the World Health Organization (WHO), around 11% of the ailments in the world are due the lack of healthy sustenance. This percentage is anticipated to rise in the near future, owing to nourishment security and changing ecological conditions. Hence, interest toward parenteral sustenance is expected to be constant. Hence, rise in awareness about parenteral nutrition therapy is likely to drive the global ethylene-vinyl acetate (EVA) infusion bags market during the forecast period.
Single Chamber to Dominate Market
In terms of chamber, the global ethylene-vinyl acetate (EVA) infusion bags market has been divided into single chamber and multi-chamber. Single chamber bags are majorly used for common intravenous solutions such as irrigation fluids, drip bags, and sterile water. Hence, the usage of single chamber bags is quite high, which, in turn, is projected to propel the segment during the forecast period.
Capacity Bags of 150 to 500 mL to be Highly Attractive
Based on capacity, the global ethylene-vinyl acetate (EVA) infusion bags market has been classified into 50 to 150 mL, 150 to 500 mL, 500 to 1,500 mL, 1,500 to 3,500 mL, and others (4,000 mL, 5,000 mL, etc.). The 150 to 500 mL segment is anticipated to dominate the global ethylene-vinyl acetate (EVA) infusion bags market during the forecast period, due to increase in the usage of 150 to 500 mL bags for delivery of various types of parenteral nutrition.
Hospitals to be Major End User
In terms of end user, the global ethylene-vinyl acetate (EVA) infusion bags market has been categorized into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment is expected to constitute significant share of the global ethylene-vinyl acetate (EVA) infusion bags market by 2030. The hospitals segment dominated the global market, owing to high usage of intravenous fluid administrations, dialysis, and minimally invasive endoscopic surgeries, and patient preference for hospitals due to amenities and facilities provided by them, favorable reimbursement policies, well-trained staff, and presence of specialist doctors and surgeons.
The report provides profiles of leading players operating in the global ethylene-vinyl acetate (EVA) infusion bags market. These include B. Braun Melsungen AG, ICU Medical, Inc., Baxter International, Inc., Fresenius Kabi AG, Technoflex, The Metrix Company, McKesson Medical-Surgical, Inc., AdvaCare Pharma, Valmed, and Haemotronic.
Global Ethylene-vinyl Acetate (EVA) Infusion Bags Market: Segmentation
- Ethylene-vinyl Acetate (EVA) Infusion Bags Market, by Chamber
- Single Chamber
- Ethylene-vinyl Acetate (EVA) Infusion Bags Market, by Capacity
- 50 to 150 mL
- 150 to 500 mL
- 500 to 1,500 mL
- 1,500 to 3,500 mL
- Others (4,000 mL, 5,000 mL)
- Ethylene-vinyl Acetate (EVA) Infusion Bags Market, by End User
- Ambulatory Surgical Centers
- Ethylene-vinyl Acetate (EVA) Infusion Bags Market, by Region
- North America
- Rest of the Europe
- Asia Pacific
- South Korea
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC